Authors

• Changjun Yu (ORCID: https://orcid.org/0000-0002-5722-6751)
• Fengzhi Li (ORCID: https://orcid.org/0000-0002-2299-7951)
• Linrong Li (ORCID: https://orcid.org/0000-0003-4106-6463)
• Xiang Ling
• Leslie Wang
• Warren Chow (ORCID: https://orcid.org/0000-0003-0889-5841)
• Xiaojiang Cui (ORCID: https://orcid.org/0000-0002-6843-736X)
• Faqing Huang (ORCID: https://orcid.org/0000-0001-8185-7097)
• Galen Cook‐Wiens (ORCID: https://orcid.org/0000-0003-4088-6240)
• Mengmeng Liu (ORCID: https://orcid.org/0000-0003-3256-3329)

Institutions

• California Institute of Technology (US)
• Cedars-Sinai Medical Center (US)
• Roswell Park Comprehensive Cancer Center (US)
• Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
• Peking Union Medical College Hospital (CN)
• Canget BioTekpharma (United States) (US)
• University of Southern Mississippi (US)

Publication Details

Journal

Cancers

Published

2025-03-04

DOI

https://doi.org/10.3390/cancers17050881

Citations

1

Primary Topic

Nanoparticle-Based Drug Delivery

Type

article

Field-Weighted Citation Impact

0.60

Funders

• U.S. Department of Defense
• National Institutes of Health